Effects and Dangers of Oxycontin

OxyContin is oxycodone hydrochloride with a controlled release coating. It is classified as an opioid analgesic and comes in 10, 20, 40, and 80mg strengths (“OxyContin,” 2537). It was approved for use in May 1996 (McGillvray) and is a schedule II controlled substance (“OxyContin,” 2540). Oxycodone is a white crystalline power that is derived from the opium alkaloid, thebaine (“OxyContin,” 2537). Also it is a semi-synthetic narcotic with multiple actions qualitatively similar to those of morphine (“Oxyfast,” 2541). The strength of the tablet describes the amount of oxycodone per tablet as hydrochloride salt (“OxyContin,” 2537). OxyContin’s chemical formula is 5-epoxy-14-hydroxy-3-methoxy-17-methylmo

After four deaths from OxyContin overdoses the Maine State Department of Professional and Financial Regulation issued guidelines for prescribing them to avoid abuse, like tamper resistant prescription pads and extensive questioning of patients (Moore). In another newsletter, distributed to doctors the Maine Board of Licensure in Medicine, it said in order to stem illegal use, doctors should use special prescription pads that change in color when altered or forged, write out the quantity and strength and designate only one pharmacy where it can be filled (McGillvray). Some doctors even have written contracts with their patients who receive painkilling narcotics regularly (McGliivray).

common in OxyContin and Immediate Release

The initial doses should be low, about 10mg, (“OxyContin,” 2540) and the pills can be used safely with non-opioid analgesics (“OxyContin,” 2540). The drug shouldn’t be administered to pregnant women unless a physician makes the decision that the benefits outweigh the risks (“Oxyfast,” 2541). Safety and effectiveness in pediatric patients or those under the age of 18 has not been established (“OxyContin,” 2539), and this medicine poses no risk to the health care providers beyond that of any controlled substance (“OxyContin,” 2541).

Some topics in this essay:
Pharmacologist Gottbrath, Hendricks Oxycodone, OxyContin OxyContin, Hendricks OxyContin, Release OxyContin, Substances Act, Angleberger Lee’s, Placebo Percentage, , Obviously OxyContin, “oxycontin” 2540, “oxycontin” 2537, “oxycontin” 2539, gottbrath 1a, respiratory depression, adverse effects, cancer patients, “oxycontin” 2541, dr don nelson, dr don, don nelson, controlled substance “oxycontin”, analgesia “oxycontin” 2537, “oxycontin” 2540 adverse, stem respiratory centers,